New research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 shows that, with the use of continuous glucose monitoring (CGM) devices, people with type 1 diabetes can complete a marathon safely and achieve finishing times similar to runners without diabetes.